EyePoint Pharmaceuticals Ownership | Who Owns EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals Ownership Summary
EyePoint Pharmaceuticals is owned by 110.38% institutional investors, 1.14% insiders. Cormorant asset management, lp is the largest institutional shareholder, holding 15.73% of EYPT shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 3.24% of its assets in EyePoint Pharmaceuticals shares.
EYPT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | EyePoint Pharmaceuticals | 110.38% | 1.14% | -11.52% |
| Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
| Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Cormorant asset management, lp | 8.32M | 15.73% | $72.43M |
| Suvretta capital management | 5.18M | 9.78% | $45.03M |
| Blackrock | 3.76M | 7.12% | $32.75M |
| Franklin resources | 3.65M | 6.90% | $31.75M |
| Adage capital partners gp | 3.59M | 6.79% | $31.25M |
| Vanguard group | 2.77M | 5.24% | $24.14M |
| Price t rowe associates inc /md/ | 2.50M | 4.73% | $21.77M |
| Morgan stanley | 2.25M | 4.26% | $19.60M |
| T. rowe price investment management | 2.07M | 3.92% | $18.02M |
| Essex woodlands management | 1.55M | 2.93% | $13.50M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Essex woodlands management | 1.55M | 4.40% | $13.50M |
| Cormorant asset management, lp | 8.32M | 4.18% | $72.43M |
| Oracle investment management | 231.86K | 1.88% | $2.02M |
| Finepoint capital lp | 707.40K | 1.75% | $6.15M |
| Suvretta capital management | 5.18M | 1.65% | $45.03M |
| Octagon capital advisors lp | 1.09M | 1.50% | $9.51M |
| Tcg crossover management | 922.34K | 0.84% | $8.02M |
| Corton capital | 49.91K | 0.23% | $434.17K |
| Silverarc capital management | 100.00K | 0.21% | $870.00K |
| Artia global partners lp | 101.50K | 0.17% | $883.05K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Cormorant asset management, lp | 8.32M | 4.18% | 1.43M |
| Suvretta capital management | 5.18M | 1.65% | 1.41M |
| Blackrock | 3.76M | 0.00% | 977.52K |
| Tcg crossover management | 922.34K | 0.84% | 922.34K |
| Morgan stanley | 2.25M | 0.00% | 910.68K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Millennium management | 580.72K | 0.00% | -1.47M |
| Adage capital partners gp | 3.59M | 0.06% | -1.16M |
| Ra capital management | - | - | -938.59K |
| Deerfield management company, l.p. (series c) | - | - | -877.79K |
| Fiera capital | - | - | -677.04K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Tcg crossover management | 922.34K | 0.84% | 922.34K | $8.02M |
| Granahan investment management | 201.33K | 0.07% | 201.33K | $1.75M |
| Balyasny asset management | 116.19K | 0.00% | 116.19K | $1.01M |
| Wellington management group llp | 107.76K | 0.00% | 107.76K | $937.48K |
| Sg americas securities | 76.29K | 0.00% | 76.29K | $664.00K |
Sold Out
| Holder | Change |
|---|---|
| Continuum advisory | -16.00 |
| Park place capital | -23.00 |
| Principal securities | -24.00 |
| Cwm | -26.00 |
| Pnc financial services group | -28.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 157 | -10.29% | 58,402,790 | 6.20% | 110 | 1.02% | 92 | -21.37% | 44 | 18.92% |
| Mar 31, 2024 | 175 | 12.90% | 54,991,981 | 11.00% | 103 | 0.75% | 117 | 25.81% | 37 | 5.71% |
| Dec 31, 2023 | 155 | 42.20% | 49,541,998 | 47.02% | 117 | 1.52% | 93 | 45.31% | 35 | 75.00% |
| Sep 30, 2023 | 109 | 26.74% | 33,696,819 | 6.73% | 87 | 1.24% | 64 | 33.33% | 20 | -4.76% |
| Jun 30, 2023 | 86 | 22.86% | 31,573,084 | 8.45% | 84 | 1.39% | 48 | 71.43% | 21 | 5.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Franklin Biotechnology Discv A(acc)USD | 1.73M | 3.24% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.99M | 2.91% | 429.50K |
| T. Rowe Price New Horizons | 1.27M | 2.38% | -4.01K |
| US Small-Cap Growth II Equity Comp | 1.27M | 2.38% | -4.52K |
| Franklin Small Cap Growth Adv | 1.18M | 2.21% | - |
| Franklin US Small Cap Growth Equity | 1.18M | 2.21% | -12.13K |
| iShares Russell 2000 ETF | 1.29M | 1.89% | -2.90K |
| Franklin Biotechnology Discovery A | 975.63K | 1.82% | - |
| Federated Hermes Kaufmann R | 1.05M | 1.54% | 1.05M |
| Federated Hermes Kaufmann Growth | 1.05M | 1.54% | 1.05M |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 20, 2024 | DICICCO WENDY F | - | Buy | $20.00K |
| Aug 21, 2024 | ANDO GORAN | - | Buy | $39.75K |
| Aug 19, 2024 | Zaderej Karen L. | - | Buy | $99.75K |
| Aug 16, 2024 | Lurker Nancy | - | Buy | $25.00K |
| Jul 12, 2024 | GUYER DAVID R | - | Sell | $117.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | 4 | 1 |
| 2024 Q2 | 4 | 2 |
| 2024 Q1 | 2 | 25 |
| 2023 Q4 | 18 | 10 |
| 2023 Q3 | - | 18 |
EYPT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools